Search

everythinglearnresearchcommunity

for

Search:↓

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

Autoimmune markers may help diagnose and manage PCOS.

More research is needed to understand and manage angioedema in pregnant women with lupus.

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Satoyoshi syndrome can occur without causing premature ovarian failure.

Key proteins and potential drugs for treating alopecia areata were identified.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Low vitamin D levels may affect ovulation and progesterone in infertile women.